Centessa Pharmaceuticals plc Quarterly Return On Equity in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Centessa Pharmaceuticals plc quarterly/annual Return On Equity history and growth rate from Q3 2021 to Q2 2024.
  • Centessa Pharmaceuticals plc Return On Equity for the quarter ending June 30, 2024 was -63.1 %, a 16.8% decline year-over-year.
  • Centessa Pharmaceuticals plc annual Return On Equity for 2023 was -56.7 %, a 5.55% decline from 2022.
  • Centessa Pharmaceuticals plc annual Return On Equity for 2022 was -53.7 %, a 32.8% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -63.1 -9.08 -16.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -56.1 +3.66 +6.13% Jan 1, 2024 Mar 31, 2024
Q4 2023 -56.7 -2.98 -5.55% Oct 1, 2023 Dec 31, 2023
Q3 2023 -54 -1.03 -1.94% Jul 1, 2023 Sep 30, 2023
Q2 2023 -54 -8.64 -19% Apr 1, 2023 Jun 30, 2023
Q1 2023 -59.7 -22.4 -59.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -53.7 +26.3 +32.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -53 +38.2 +41.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -45.4 Apr 1, 2022 Jun 30, 2022
Q1 2022 -37.4 Jan 1, 2022 Mar 31, 2022
Q4 2021 -80 Oct 1, 2021 Dec 31, 2021
Q3 2021 -91.2 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.